143 related articles for article (PubMed ID: 7785467)
1. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro.
Moonga BS; Dempster DW
J Bone Miner Res; 1995 Mar; 10(3):453-7. PubMed ID: 7785467
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
4. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
Hall TJ; Schaeublin M; Chambers TJ
Biochem Biophys Res Commun; 1993 Sep; 195(3):1245-53. PubMed ID: 8216256
[TBL] [Abstract][Full Text] [Related]
5. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone.
Hattersley G; Dorey E; Horton MA; Chambers TJ
J Cell Physiol; 1988 Oct; 137(1):199-203. PubMed ID: 3262621
[TBL] [Abstract][Full Text] [Related]
6. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
[TBL] [Abstract][Full Text] [Related]
7. The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
Hall TJ; Nyugen H; Schaueblin M; Fournier B
Biochem Biophys Res Commun; 1995 Nov; 216(2):662-8. PubMed ID: 7488162
[TBL] [Abstract][Full Text] [Related]
8. Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo.
van der Pluijm G; Binderup L; Bramm E; van der Wee-Pals L; De Groot H; Binderup E; Löwik C; Papapoulos S
J Bone Miner Res; 1992 Aug; 7(8):981-6. PubMed ID: 1442212
[TBL] [Abstract][Full Text] [Related]
9. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
11. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
12. Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents.
Kneissel M; Studer A; Cortesi R; Susa M
Bone; 2005 Feb; 36(2):202-14. PubMed ID: 15780946
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
14. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
Yamaguchi M; Uchiyama S
J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
[TBL] [Abstract][Full Text] [Related]
15. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
16. Effects of wortmannin analogs on bone in vitro and in vivo.
Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
[TBL] [Abstract][Full Text] [Related]
17. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
Wezeman FH; Kuettner KE; Horton JE
Anat Rec; 1979 Jul; 194(3):311-23. PubMed ID: 224732
[TBL] [Abstract][Full Text] [Related]
18. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
[TBL] [Abstract][Full Text] [Related]
19. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption.
Greig IR; Idris AI; Ralston SH; van't Hof RJ
J Med Chem; 2006 Dec; 49(25):7487-92. PubMed ID: 17149877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
